Showing results (41-50 of 64) with videos related to
Sort By:
Pageof 7
Investigational New Drugs|December 21, 2010
A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancerDaniel J Renouf, Malcolm J Moore, David Hedley, et al.European Journal of Cancer (Oxford, England : 1990)|September 6, 2012
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: a large retrospective studyThomas Walter, Anne M Horgan, Mairead McNamara, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancerHelen Mackay, David Hedley, Pierre Major, et al.Breast Cancer Research and Treatment|April 27, 2007
A Phase 2 study of perifosine in advanced or metastatic breast cancerNatasha B Leighl, Susan Dent, Mark Clemons, et al.Journal of Gastrointestinal Cancer|August 18, 2018
Tumor Platinum Concentrations and Pathological Responses Following Cisplatin-Containing Chemotherapy in Gastric Cancer PatientsYanshuo Cao, Qing Chang, Michael Cabanero, et al.Leukemia & Lymphoma|January 30, 2010
A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group StudyMichael Crump, David Hedley, Suzanne Kamel-Reid, et al.British Journal of Cancer|July 22, 2022
Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancerMark K Doherty, Vincent C Tam, Mairéad G McNamara, et al.American Journal of Clinical Oncology|January 1, 2010
A multicenter phase II clinical trial of lapatinib (GW572016) in hormonally untreated advanced prostate cancerSrikala S Sridhar, Sebastien J Hotte, Joseph L Chin, et al.American Journal of Clinical Oncology|February 28, 2014
Outcome of adjuvant therapy in biliary tract cancersMairead G McNamara, Thomas Walter, Anne M Horgan, et al.Science Advances|May 8, 2021
NOX4 links metabolic regulation in pancreatic cancer to endoplasmic reticulum redox vulnerability and dependence on PRDX4Pallavi Jain, Anna Dvorkin-Gheva, Erik Mollen, et al.Pageof 7